Adverse events in patients with leprosy on treatment with thalidomide
Rev. Soc. Bras. Med. Trop
;
52: e20180385, 2019. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1041594
ABSTRACT
Abstract INTRODUCTION: Thalidomide, used to treat erythema nodosum leprosum (ENL), is associated with severe adverse events (AEs) and is highly teratogenic. METHODS: A cross-sectional study was conducted on thalidomide-treated patients with ENL. AEs and selected variables were investigated through interviews and assessment of medical records. Odds ratios with 95% confidence intervals were estimated via logistic regression. RESULTS: Peripheral neuropathy symptoms and deep vein thrombosis (DVT) were the most common AEs reported. Although women of reproductive age used contraceptives, <50% of patients reported using condoms. Polypharmacy was associated with all endpoints, except DVT. CONCLUSIONS: Pharmacovigilance is crucial to prevent harmful thalidomide-associated AEs.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Talidomida
/
Leprostáticos
/
Lepra
Tipo de estudio:
Estudio observacional
/
Estudio de prevalencia
/
Factores de riesgo
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
Medicina Tropical
Año:
2019
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Fundação Ezequiel Dias/BR
/
Universidade Federal de Minas Gerais/BR
Similares
MEDLINE
...
LILACS
LIS